Correlation Between Inozyme Pharma and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and AN2 Therapeutics, you can compare the effects of market volatilities on Inozyme Pharma and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and AN2 Therapeutics.
Diversification Opportunities for Inozyme Pharma and AN2 Therapeutics
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inozyme and AN2 is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Inozyme Pharma and AN2 Therapeutics
Given the investment horizon of 90 days Inozyme Pharma is expected to generate 0.74 times more return on investment than AN2 Therapeutics. However, Inozyme Pharma is 1.35 times less risky than AN2 Therapeutics. It trades about 0.06 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 115.00 in Inozyme Pharma on September 14, 2024 and sell it today you would earn a total of 185.00 from holding Inozyme Pharma or generate 160.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. AN2 Therapeutics
Performance |
| Timeline |
| Inozyme Pharma |
| AN2 Therapeutics |
Inozyme Pharma and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and AN2 Therapeutics
The main advantage of trading using opposite Inozyme Pharma and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| AN2 Therapeutics vs. Puma Biotechnology | AN2 Therapeutics vs. Iovance Biotherapeutics | AN2 Therapeutics vs. Day One Biopharmaceuticals | AN2 Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |